Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02073916
Title TDM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer
Acronym STELA
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors The Methodist Hospital System
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Houston Methodist Hospital Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field